Latest Barr Virus Stories
SEATTLE, Aug. 11 /PRNewswire/ -- HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection.
Scientists of Helmholtz Zentrum MÃ¼nchen have elucidated a crucial mechanism in the lytic cycle of Epstein-Barr virus.
NEW YORK, Sept.
ROCHESTER, N.Y., Sept. 21 /PRNewswire/ -- According to Dr. Ila R. Singh, an associate professor of pathology at the University of Utah, "for the first time we have analyzed prostate cancer and normal prostate tissue and found cancers are much more likely to have [the XMRV virus] ...
SAN FRANCISCO, March 24 /PRNewswire/ -- Epiphany Biosciences announced today that the company plans on filing an IND with the Food and Drug Administration (FDA) to study the potential impact of using the antiviral medication valomaciclovir (EPB-348) as an adjunctive therapy in the treatment of multiple sclerosis. Valomaciclovir has been shown to possess potent antiviral activity in vitro against a number of herpes-related viruses, including herpes simplex (HSV), Epstein-Barr virus (EBV),...
The Epstein-Barr virus (EBV), or human herpesvirus 4, is part of the herpes family and causes cancer. It is one of the most common viruses in humans and is correlated to the pathogenesis of multiple autoimmune diseases including rheumatoid arthritis, systemic lupus, dermatomyositis, and multiple sclerosis. It can also cause several lymphoproliferative disorders and cancers. Most people gain adaptive immunity after being infected by EBV. In the US half of all five-year-olds and 90-95% of...
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.